Floatz logo

AIR

Hemicrania Continua

The University of Texas Health Science Center, HoustonmixturePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Hemicrania Continua cohort.

Same molecule, other indications

AIR is also rated in:

migraine disorderDormant
B
Indicative ·
58 / 100
View asset →
neuralgiaDormant
B
Indicative ·
57 / 100
View asset →
brain injuryDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →